Healthcare Sales & Marketing Network News: etripamil

Searching News Database: etripamil

HSMN NewsFeed - 17 Oct 2022
Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 May 2021
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 10 Sep 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.